Member Info for OAPK20

If all placing warrants are exercised then that’s £ 7,200,000.60 to ENET. So at a guess is effectively similar to a placing.
Taking shares in issue to 82,276,260 which is not many shares in issue.
The rest you would need to check the old RNS for additional warrants (5G for eg) and company website.

Warrants from recent placing. Term life 18 months from date of admission.

Investors to receive warrants on a 1 for 1 basis, exercisable at 60p, with 'accelerator clause' when the share price reaches 80p for 5 consecutive days.
12000001 shares issued.

Transaction Rationale

-- Montepuez is an in-construction high grade flake graphite project while Balama Central is an advanced stage feasibility ready project located in an established graphite producing district of Mozambique;

-- The Acquisition provides resource diversity to support the Company's strategy of being a global leader in flake graphite, adding substantial JORC Code (2012) resources and reserves to complement its existing resources of high-quality large flake graphite in Madagascar;

-- The additional mineral resources and reserves lay the foundation for the Company to capitalise on the visible market opportunities emanating from the growth of e-mobility and energy storage, fire safety, thermal management, advanced materials and composites;

-- The Acquisition will enable the Company to achieve its stated strategy of diversifying country risk with a second primary resource location and provide advantages of higher-grade deposits with c.9-10% TGC;

-- The c.60-70% medium and small flake graphite anticipated from the projects, which are preferred by certain end users in the lithium-ion battery anode and are a feed stock for micronized graphite, enable the Company to prioritise its premium jumbo and large flake Madagascan resources to premium markets for these products and applications.

Key Transaction Terms

-- Subject to the satisfaction of the conditions to the transaction, the Company will acquire from Battery Minerals 100% of the issued share capital of Suni Resources (a Mozambique incorporated subsidiary of Battery Minerals), all related intellectual property relating to the Montepuez Project and Balama Central Project, and will be assigned the shareholder loans owed by Suni Resources to certain Battery Minerals group companies amounting to c.AU$29 million for a total aggregate consideration of AU$12.5 million;

Upon completion, the Company intends to further optimise the project development plans leveraging application of its extensive and proven expertise in developing graphite projects to minimise investment and optimise operating costs while looking to retain the plans to implement 2 x 50,000 tpa modules plan owing to visible market opportunities in the green economy; and

-- Solidifies the Company's divisional structure of primary mining and processing projects in Madagascar, Sahamamy and Vatomina, and speciality graphite and graphene processing businesses in India.

The Acquisition is in line with the Company's stated strategy of diversifying its resource base and mitigating country risk;

-- Two complementary world-class graphite deposits, spread over a combined 18,500 hectares permit area adding mineral resources of over 152 million tonnes at 8.5% TGC, significantly increasing the Company's JORC Code (2012) mineral resource base;

-- Extensive pre-development work and a Definitive Feasibility Study ("DFS") has been conducted by Battery Minerals on the Montepuez project, resulting in a development plan for a 100,000 tonnes annual graphite concentrate capacity in two equal stages;

-- Construction was initiated at the Montepuez project for a first stage 50,000 tpa flake graphite project with c. 100 person base camp, plant area grading and tailing dam construction substantially completed and certain long lead equipment including crusher unit ordered for the development of the project;

-- The projects graphite product basket is a mix of jumbo, large and small flake, complementing Tirupati's existing mix of predominantly jumbo and large flake graphite products from Madagascar;

Similar PRICE movement to CEO sell and option execution.

Wonder if the OTHER 2 are releasing funds for expenses and tax liabilities?

Or £ 133,108.20
Late reported shows as a buy.
A short closing/reducing maybe.

Shorters will bury this with inane arguments about hee haw to do with CINE.

They don’t want buying pressure to increase the SP as they try to close their positions.

Or £ 133,108.20
Late reported shows as a buy.
A short closing/reducing maybe.

Sorry £ 133,108.20 reported as a buy

That’s £ 133,108.29 reported as a buy

Late reported shows as a buy.
A short closing/reducing maybe.

Pull up your socks

Late reported shows as a buy.
A short closing/reducing maybe.

Shorters don’t want to highlight incase buying pressure starts Monday

Late reported shows as a buy.
A short closing/reducing maybe.

Late reported shows as a buy.
A short closing/reducing maybe.

In case it’s buried in the inane personal posts

Late reported shows as a buy.
A short closing/reducing maybe.

Be interesting to see if the CFO and COO follow suit too. Might be another couple of RNS announcements to come.

Performance-Based Requirement:
(i) In respect of 70% of the options (rounded to the nearest whole number) no option may be exercised until the date on which the arithmetic mean closing price of the Company's shares over 30 consecutive trading dates after the date of grant has exceeded 15p per share; and
(ii) In respect of the balance of the options, no options may be exercised until the date on which the arithmetic mean closing price of the Company's shares over 30 consecutive trading days after the date of grant has exceeded 27p per share.
Service-Based Requirement: for all United States employees no option shall be exercised before the two-year anniversary of the date of grant.
Those options that have not vested will expire after five years from the date of grant. All options are also fully convertible at the discretion of the Remuneration Committee of the Company.
Of the options granted, the following awards have been made to the executive directors, being Chris Richards, Jeffrey Hovey and Jeffrey Tweedy.

Chief Executive Officer
Christopher Richards -3,250,000

Chief Financial Officer Jeffrey Hovey -1,181,818

Chief Operating Officer Jeffrey Tweedy -1,181,818

18:03 RNS today
RNS Number : 7314P
Plant Health Care PLC
20 October 2021
The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.
Plant Health Care plc
("Plant Health Care" or "the Company")
Exercise of Options, Issue of Equity, Director / PDMR Shareholding
and Total Voting Rights
Plant Health Care, a leading provider of novel patent-protected biological products to global agricultural markets, announce s that on 20 October 202 1 Christopher Richards, Chief Executive Officer, exercised options
As announced on 7 October 2020, the Company had awarded 3,250,000 Options to Christopher Richards with an exercise price of 1p per ordinary share in the Company (the ' Ordinary Shares ') under the Plan that vest upon the earlier of: (a) the date of a Change of Control; or (b) upon satisfaction of the Performance-Based Requirement. The Performance-Based Requirement i n respect of 70% of the O ptions (rounded to the nearest whole number) is that no O ption may be exercised until the date on which the arithmetic mean closing price of the Ordinary S hares over 30 consecutive trading dates after the date of grant has exceeded 15p per S hare . This criteria was achieved earlier this year and Dr Richards has now decided to exercise 2,275,000 Options.
Of the 2,275,000 Ordinary Shares to be issued (the ' New Ordinary Shares ') following the exercise of the Options, Christopher Richards has sold 879,042 Ordinary Shares at an aggregate price of GBP100,146.06, being enough Ordinary Shares to cover the exercise price and associated tax liabilities in respect of the Ordinary Shares issued. Following these transactions, Dr Richards is interested in 4,370,973 Ordinary Shares representing 1.43% of the issued share capital of the Company.
Application for admission of the New Ordinary Shares to trading on AIM ('Admission') has been made and dealings in the New Ordinary Shares are expected to commence at 8.00 a.m. on 26 October 2021. The New Ordinary Shares will rank pari-passu with the Company's existing issued Ordinary Shares.
Total voting rights
Following Admission, the Company will have 304,662,482 Ordinary Shares in issue with no shares held in treasury. This is the total number of voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.